Dr. Delitto is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Palo Alto, CA 94304Phone+1 650-723-4000
Summary
- Dr. Delitto is a fellowship-trained surgical oncologist with a focus on conditions of the liver, pancreas, and stomach. He is an assistant professor in Stanford Medicine’s Department of Surgery.
His education includes a decade of postgraduate training in complex general surgical oncology, as well as a PhD in immunology with an emphasis on cancer biology. He completed a clinical fellowship at Johns Hopkins University and continued his research at the postdoctoral level in the laboratory of Dr. Elizabeth Jaffee. His research focus is on advancing the field of cancer immunology and harnessing his findings to improve immunotherapies.
He was the principal investigator of two studies examining the immune response to pancreatic cancer, including one funded by the National Cancer Institute.
Dr. Delitto has presented the findings of his research at conferences such as the American Association for Cancer Research, Society for the Immunotherapy of Cancer, American Association of Immunologists, American College of Surgeons, Academic Surgical Congress and Pancreas Club. In addition to cancer immunology, he has also presented work focused on cancer cachexia, surgical outcomes, translational experimental models and a variety of other oncologic topics.
He has published original work in Nature Communications, the Journal of the National Cancer Institute, Cancer Research, Clinical Cancer Research, and other high impact journals. He is also a reviewer for Annals of Surgery, Scientific Reports, Surgery, Tumor Biology, Journal of Surgical Research, PLOS ONE, and the Journal of Translational Medicine.
Dr. Delitto has earned numerous honors related to clinical excellence, teaching and research. He is board certified by the American Board of Surgery and a member of the Society of Surgical Oncology, American Association for Cancer Research and American Association of Immunologists.
Education & Training
- Johns Hopkins University School of MedicineFellowship, Complex General Surgical Oncology, 2019 - 2021
- University of FloridaResidency, Surgery, 2011 - 2019
- University of Florida College of MedicinePhD, Immunology, 2013 - 2016
- University of Pittsburgh School of MedicineClass of 2011
Certifications & Licensure
- CA State Medical License 2021 - 2025
- MD State Medical License 2019 - 2022
- American Board of Surgery Surgery
- American Board of Surgery Complex General Surgical Oncology
Publications & Presentations
PubMed
- Biochemical, Radiographic, or Pathologic Response to Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: Which is Best?M Usman Ahmad, Christopher S Javadi, Julia D Chang, Erna Forgó, Daniel J Delitto
Annals of Surgery. 2024-12-16 - 1 citationsCirculating Tumor DNA in the Monitoring of Soft Tissue Sarcoma Treatment and Recurrence.Beatrice J Sun, Amy Y Li, Dong G Hur, Maggie Zhou, George A Poultsides
Annals of Surgical Oncology. 2024-11-01 - Distal Pancreatectomy with and without Celiac Axis Resection for Adenocarcinoma: A Comparison in the Era of Neoadjuvant Therapy.Sara K Daniel, Camille E Hironaka, M Usman Ahmad, Daniel Delitto, Monica M Dua
Cancers. 2024-10-12
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: